Advertisements


Is Pot Stock GW Pharmaceuticals Undervalued?

The upcoming launch of its marijuana medicine for epilepsy could send sales surging......»»

Category: topSource: foxnewsSep 21st, 2018

Rigel Pharmaceuticals Stock Shows Every Sign Of Being Modestly Undervalued

Related Stocks: RIGL,.....»»

Category: smallbizSource: nytApr 19th, 2021

Ligand Pharmaceuticals Stock Gives Every Indication Of Being Modestly Undervalued

Related Stocks: LGND,.....»»

Category: worldSource: nytApr 17th, 2021

Supernus Pharmaceuticals Stock Appears To Be Significantly Undervalued

Related Stocks: SUPN,.....»»

Category: blogSource: gurufocusApr 4th, 2021

BioCryst surges 30% to a 5-year high as Redditors declare "BioWar" against short-sellers

Shares of BioCryst Pharmaceuticals soared to a five-year high as some Redditors call it "the most undervalued stock in the m.....»»

Category: topSource: businessinsiderFeb 1st, 2021

Is Pot Stock GW Pharmaceuticals Undervalued?

The upcoming launch of its marijuana medicine for epilepsy could send sales surging......»»

Category: topSource: foxnewsSep 21st, 2018

Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?

EyePoint Pharmaceuticals reveals Phase 2 PAVIA trial results for Duravyu in non-proliferative diabetic retinopathy. Positive data showcases Duravyu's efficacy and safety profile. read more.....»»

Category: blogSource: benzinga10 hr. 43 min. ago

Why Is NRx Pharmaceuticals Stock Falling After Data From Suicidal Bipolar Depression Study

NRX Pharmaceuticals announces Phase 2b/3 trial findings of NRX-101 vs. Lurasidone for Suicidal Bipolar Depression. read more.....»»

Category: blogSource: benzingaApr 30th, 2024

This Undervalued Cannabis Stock Has Another Year Of Growth: Reports Record 2023 Revenue And Adjusted EBITDA

Decibel Cannabis Company reported on Monday its audited financial results for the three and twelve month periods ending Dec. 31, 2023. The Calgary, Alberta-based company said it saw .....»»

Category: blogSource: benzingaApr 29th, 2024

This Undervalued Cannabis Stock Has Another Year Of Growth: Reports Record 2023 Revenue And Adjusted EBITDA

Decibel Cannabis Company Inc. (TS.....»»

Category: earningsSource: benzingaApr 29th, 2024

Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends

Incyte acquires Escient Pharmaceuticals for $750 million, bolstering its pipeline. Cantor Fitzgerald initiates coverage with a Neutral rating, citing undervaluation concerns despite strong cash flow. Latest Ratings for INCY DateFirmActio.....»»

Category: blogSource: benzingaApr 23rd, 2024

Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors" Radars Today

On Wednesday, key U.S. stock indexes closed lower, as the Dow Jones I.....»»

Category: blogSource: benzingaApr 10th, 2024

FA Center: Why it matters to the stock if Facebook is a tech company or a media play

In one of these industries Facebook shares are undervalued, which influences the stock price......»»

Category: topSource: marketwatchMay 26th, 2021

Pieris stock rockets on record volume after Genentech collaboration valued at up to $1.4 billion

Shares of Pieris Pharmaceuticals Inc. rocketed 57.3% on massive volume in afternoon trading Tuesday, after the Boston-based biotechnology company announced a respiratory and ophthalmology collaboration with Roche Holding AG's .....»»

Category: topSource: marketwatchMay 25th, 2021

What"s Going On With Pieris Pharmaceuticals Stock Today?

Pieris Pharmaceuticals Inc (NASDAQ: PIRS) shares are trading higher by 57% at $2.91 after the company announced a respiratory and ophthalmology collaboration with Genentech. read more.....»»

Category: blogSource: benzingaMay 25th, 2021

Anebulo Pharmaceuticals started at buy with $15 stock price target at Benchmark

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 25th, 2021

Xeris Pharmaceuticals to acquire Strongbridge Biopharma for $267M in stock, CVRs

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 24th, 2021

Xeris Pharmaceuticals to acquire Strongbridge in stock, CVR transaction

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 24th, 2021

Pieris Pharmaceuticals files to sell 3.58M shares of common stock for holders

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 17th, 2021

Armata Pharmaceuticals files to sell 12.3M shares of common stock for holders

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 13th, 2021

Eloxx Pharmaceuticals announces common stock offering, no amount given

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 13th, 2021